BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30571774)

  • 1. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.
    Kumagai J; Taida T; Ogasawara S; Nakagawa T; Iino Y; Shingyoji A; Ishikawa K; Akizue N; Yamato M; Takahashi K; Ohta Y; Hamanaka S; Okimoto K; Nakamura M; Ohyama H; Saito K; Kusakabe Y; Maruoka D; Yasui S; Matsumura T; Sugiyama H; Sakai Y; Mikata R; Arai M; Katsuno T; Tsuyuguchi T; Kato N
    PLoS One; 2018; 13(12):e0209352. PubMed ID: 30571774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.
    Park YE; Cheon JH; Park JJ; Kim YJ; Choi CH; Park Y; Park SJ; Kim TI; Kim WH
    Int J Colorectal Dis; 2018 Oct; 33(10):1497-1500. PubMed ID: 29987360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea.
    Ye BD; Yang SK; Boo SJ; Cho YK; Yang DH; Yoon SM; Kim KJ; Byeon JS; Myung SJ; Yu CS; Yun SC; Kim JH
    Inflamm Bowel Dis; 2011 Sep; 17(9):1901-6. PubMed ID: 21830268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
    Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
    Wang MH; Mousa OY; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Cushing KC; Monroe K; Nix BD; Newberry RD; Faubion WA
    Inflamm Bowel Dis; 2020 Apr; 26(5):774-779. PubMed ID: 31626701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis.
    Lundberg Båve A; Olén O; Söderling J; ; Ludvigsson JF; Bergquist A; Nordenvall C
    United European Gastroenterol J; 2023 Jun; 11(5):471-481. PubMed ID: 37169725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characteristics of pediatric ulcerative colitis with primary sclerosing cholangitis: A single-center study in Taiwan.
    Chien MM; Chang MH; Chang KC; Chiu YC; Chen HL; Hsu HY; Wu JF
    Pediatr Neonatol; 2021 Sep; 62(5):483-490. PubMed ID: 34074613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
    Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
    Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.
    Khan N; Trivedi C; Shah Y; Cole E; Lewis J; Yang YX
    Inflamm Bowel Dis; 2018 Aug; 24(9):2062-2067. PubMed ID: 29697792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis.
    Leidenius MH; Färkkilä MA; Kärkkäinen P; Taskinen EI; Kellokumpu IH; Höckerstedt KA
    Scand J Gastroenterol; 1997 Jul; 32(7):706-11. PubMed ID: 9246712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis.
    Han IS; Baek DH; Hong SM; Lee BE; Lee MW; Kim GH; Song GA
    Int J Colorectal Dis; 2023 Jun; 38(1):175. PubMed ID: 37349585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
    Ellinghaus D; Folseraas T; Holm K; Ellinghaus E; Melum E; Balschun T; Laerdahl JK; Shiryaev A; Gotthardt DN; Weismüller TJ; Schramm C; Wittig M; Bergquist A; Björnsson E; Marschall HU; Vatn M; Teufel A; Rust C; Gieger C; Wichmann HE; Runz H; Sterneck M; Rupp C; Braun F; Weersma RK; Wijmenga C; Ponsioen CY; Mathew CG; Rutgeerts P; Vermeire S; Schrumpf E; Hov JR; Manns MP; Boberg KM; Schreiber S; Franke A; Karlsen TH
    Hepatology; 2013 Sep; 58(3):1074-83. PubMed ID: 22821403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
    Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Lööf LA; Sandberg-Gertzén H; Almer S; Askling J; Ehlin A; Ekbom A
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):939-43. PubMed ID: 18674735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.
    Sano H; Nakazawa T; Ando T; Hayashi K; Naitoh I; Okumura F; Miyabe K; Yoshida M; Takahashi S; Ohara H; Joh T
    J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):154-61. PubMed ID: 20740366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
    Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Fattahi MR; Malek-Hosseini SA; Sivandzadeh GR; Safarpour AR; Bagheri Lankarani K; Taghavi AR; Ejtehadi F
    Inflamm Bowel Dis; 2017 Jul; 23(7):1160-1167. PubMed ID: 28520586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.